Artepharm Global Corp. has acquired the patent and the worldwide marketing rights for Artequick®, a natural artemisinin-based anti-malaria drug that uses a western pharmaceutical delivery system, from Artepharm Co., a company based out of the People’s Republic of China. Artepharm Global Corp. trades on the NASDAQ OTCBB market under the symbol ARGC.